Analysis of hemochromatosis gene mutations in the sicilian population: Implications for survival and longevity

Archives of Gerontology and Geriatrics

Volumn 35, Issue SUPPL. 8, 2002, Pages 35-42

  Balistreri, C R ^a   Candore, G ^a   Almasio, P ^b   Di Marco, V ^b   Colonna Romano, G ^a   Craxi, A ^b   Motta, M ^c   Piazza, G ^a   Malaguarnera, M ^c   Lio, D ^a   Caruso, C ^a  

^a Dept Biopathology/Biomed Methodol   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Centenarians; Chronic liver diseases; HFE; High serum ferritin

Indexed keywords

FERRITIN; HLA ANTIGEN CLASS 1;

ADULT; AGED; ALLELE; CHRONIC LIVER DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; EUROPE; FEMALE; FERRITIN BLOOD LEVEL; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC RISK; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LONGEVITY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RISK; PRIORITY JOURNAL; SURVIVAL;

EID: 0036990048     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4943(02)00101-2     Document Type: Conference Paper

References (33)

1. Armitage, P. (1971): Statistical Methods in Medical Research. Blackwell Scientific Publications, London
2. Bacon, B.R., Farahvash, M.J., Janney, C.G. and Neuschwander-Tetri, B.A. (1994): Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology, 107, 1103-1109.
3. Bacon, B.R., Powell, L.W., Adams, P.C., Kresina, T.F. and Hoofnagle, J.H. (1999): Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology, 116, 193-207.
4. Bathum, L., Christiansen, L., Nybo, H., Ranberg, K.A., Gaist, D., Jeune, B., Petersen, N.E., Vaupel, J. and Christensen, K. (2001): Association of mutations in the hemochromatosis gene with shorter life expectancy. Arch. Intern. Med., 161, 2441-2444.
5. Bonkovsky, H.L., Banner, B.J. and Rothman, A.L. (1997): Iron and chronic viral hepatitis. Hepatology, 25, 759-768.
6. Campo, S., Restuccia, T., Villari, D., Raffa, G., Cucinotta, D., Squadrito, G., Pollicino, T. and Raimondo, G. (2001): Analysis of hemochromatosis gene mutations in a population from the Mediterranean Basin. Liver, 21,233-236.
7. Carru, C., Pes, G.M., Deiana, L., Baggio, G., Franceschi, C., Lio, D., Balistreri, C.R., Candore, G., Colonna Romano, G., and Caruso, C. (2002): Association between the HFE mutations and longevity: a study in Sardinian population. Mech. Ageing Dev., (in press).
8. Caruso, C., Candore, G., Colonna Romano, G., Lio, D., Bonafe, M., Valensin, S. and Franceschi, C. (2000): HLA, aging and longevity: a critical reappraisal. Hum. Immunol., 61,942-949.
9. Cassanelli, S., Pignatti, E., Montosi, G., Garuti, C., Mariano, M., Campioli, D., Carbonieri, A., Baldini, E. and Pietrangelo, A. (2001): Frequency and biochemical expression of C282Y/H63D haemochromatosis (HFE) gene mutations in the healthy adult population in Italy. J. Hepatol., 34, 523-528.
10. Distante, S., Berg, J.P., Lande, K., Haug, E. and Bell, H. (1999): High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo, and its phenotypic expression. Scand. J. Gastroenterol., 34, 529-534.
11. Feder, J.N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D.A., Basava, A., Dormishian, F., Domingo, R.jr., Ellis, M.C., Fullan, A., Hinton, L.M., Jones, N.L., Kimmel, B.E., Kronmal, G.S., Lauer, P., Lee, V.K., Loeb, D.B., Mapa, F.A., McClelland, E., Meyer, N.C., Mintier, G.A., Moeller, N., Moore, T., Morikang, E. And Wolff, R.K. (1996): A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet., 13, 399-408.
12. Feder, J.N., Penny, D.M., Irrinki, A., Lee, Lebron, J.A., Watson, N., Tsuchihashi, Z., Sigal, E., Bjorkman, P.J. and Schatzman, R.C. (1998): The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc. Natl. Acad. Sci. USA, 95, 1472-1477.
13. Haddow, J.E. and Bradley, L.A. (1999): Hereditary haemochromatosis: to screen or not. Conditions for screening are not yet fulfilled. Brit. Med..J., 319, 531-532.
14. Hohler, T., Leininger, S., Kohler, H.H., Schirmacher, P. and Galle, P.R. (2000): Heterozygosity for the hemochromatosis gene in liver diseases - prevalence and effects on liver histology. Liver, 20, 482-486.
15. Lio, D., Balistreri, C.R., Colonna Romano, G., Motta, M., Franceschi, C., Malaguarnera, M., Candore, G. and Caruso, C. (2002a): Association between the MHC class I gene HFE polymorphisms and longevity: a study in Sicilian population. Genes Immun., 3, 20-24.
16. Lio, D., Pes, G.M., Carru, C., Listi, F., Ferlazzo, V., Candore, G., Colonna Romano, G., Ferrucci, L., Deiana, L., Baggio, G., Franceschi, C. and Caruso, C. (2002b): Association between the HLA-DR alleles and longevity: a study in Sardinian population. Exp. Gerontol., (submitted).
17. Ludwig, J., Hashimoto, E., Proayko, M.K., Moyer, T.P. and Baldus, W.P. (1997): Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology, 112, 882-888.
18. Marshall, D.S., Linfert, D.R. and Tsongolis, G.J. (1999): Prevalence of the C282Y and H63D polymorphisms in a multi-ethnic control population. Int. J. Mol. Med., 4, 389-393.
19. Miller, S.A., Dykes, D.D. and Polasky, H.F. (1998): A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 16, 1215.
20. Moalem, S., Percy, M.E., Andrews, D.F., Kruck, T.P., Wong, S., Dalton, A.J., Mehta, P., Fedor, B and Warren, A.C. (2000): Are hereditary hemochromatosis mutations involved in Alzheimer disease? Am. J. Med. Genet., 93, 58-66.
21. Mura, C., Ragnenes, D. and Ferec, C. (1999): HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood, 93, 2502-2505.
22. Olynyk, J.K., Cullen, D.J., Aquilia, S., Rossi, E., Summerville, L. And Powell, L.W. (1999): A population based study of the clinical expression of the hemochromatosis gene. N. Engl. J. Med., 341, 718-724.
23. Papanikolaou, G., Politou, M., Terpos, E., Fourlemadis, S., Sakellaropoulos, N. and Loukopoulos, D. (2000): Hereditary hemochrornatosis: HFE mutation analysis in Greeks reveals genetic heterogeneity. Blood Cells Mol. Dis., 26, 163-168.
24. Pozzato, G., Zorat, F., Nascimben, F., Gregorutti, M., Comar, C., Baracetti, S., Vatta, S., Bevilacqua, E., Belgrano, A., Crovella, S. and Amoroso, A. (2001): Haemochromatosis gene mutations in a clustered Italian population: evidence of high prevalence in people of Celtic ancestry. Eur. J. Hum. Genet., 9, 445-451.
25. Rasmussen, M.L., Folasom, A.R., Catellier, DoJ., Tsai, M.Y., Garg, U. and Eckfeldt, J.H. (2001): A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis, 154, 739-746.
26. Rochette, J., Pointon, J.J., Fisher, C.A., Perera, G., Arambepola, M., Arichchi, D.S., De Silva, S., Vandwalle, J.L., Monti, J.P., Old, J.M., Merryweather-Clarke, A.T., Weatherall, D.J. and Robson, K.J. (1999): Multicentric origin of hemochromatosis gene (HFE) mutations. Am. J. Hum. Genet., 64, 1056-1062.
27. Roest, M., Van der Schouw, Y.T., De Valk, B., Marx, J.J., Tempelman, M.J., De Groot, P.G., Sixma, J.J. and Banga, J.D. (1999): Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation, 100, 1268-1273.
28. Sampietro, M., Caputo, L., Casatta, A., Meregalli, M., Pellagatti, A., Tagliabue, J., Annoni, G. and Vergani, C. (2001): The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease. Neurobiol. Aging, 22, 563-568.
29. Smith, B.C., Gorve, J., Guzail, M.A., Day, C.P., Daly, A.K., Burt, A.D. and Bassendine, M.F. (1998): Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology, 27, 1695-1699.
30. Smith, M.A., Harris, P.L., Sayre, L.M. and Perry, G. (1997): Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. USA, 94, 9866-9868.
31. Sullivan, J.L. (1990): Heterozygous hemochromatosis as a risk factor for premature myocardial infarction. Med. Hypotheses, 31, 1-5.
32. Tuomainen, T.P., Kontula, K, Nyyssonen, K., Lakka, T.A., Helio, T. and Salonen, J.T. (1999): Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: a prospective cohort study in men in eastern Finland. Circulation, 100, 1274-1279.
33. Yang, Q., McDonnell, S.M., Khoury, M.J., Cono, J. and Parrish, R.G. (1998): Hemochromatosis-associated mortality in the United States from 1979 to 1992: an analysis of multiple-cause mortality data. Ann. Intern. Med., 129, 946-953.